Drug company pushes for all children under 2 to be vaccinated against pneumonia
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7426.1249-a (Published 27 November 2003) Cite this as: BMJ 2003;327:1249
- Leanne Tite
- BMJ
The pharmaceutical company Wyeth has launched a campaign to persuade the UK government to extend the use of its children's pneumococcal vaccine to all children under the age of 2. Currently, the Department of Health recommends it use only in children who are at risk because of chronic disease.
The move follows recent data published in the New England Journal of Medicine showing indications of an early success for the US paediatric pneumococcal immunisation programme (2003;348:1737-46). Figures compiled by the Centers for Disease Control and Prevention, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.